Literature DB >> 15292526

Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.

R Smith1, L Barnsley, S Kannangara, A Mace.   

Abstract

Rheumatologists, with their musculoskeletal background, often care for athletes. The effect of a positive anti-doping test, whether through illegitimate use or accidental prescribing of banned drugs, is devastating to an athlete's career. It is therefore incumbent upon rheumatologists to be aware of issues relating to drugs in sport. This involves both therapeutic drugs and doping. It is vital to ensure that any substance prescribed should be approved for use and should not adversely affect (or benefit) the athlete's performance. In March 2004, 5 months prior to the 2004 Olympic Games in Athens, the joint World Anti-Doping Agency/International Olympic Committee published the revised list of banned substances in athletes. This article aims to provide an overview of the current status of medications commonly prescribed in rheumatological practice.

Mesh:

Substances:

Year:  2004        PMID: 15292526     DOI: 10.1093/rheumatology/keh338

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  1 in total

Review 1.  London 2012: prescribing for athletes in ophthalmology.

Authors:  R G H Nicholson; G P L Thomas; M J Potter; J H Norris
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.